Phreesia, Inc. (NYSE:PHR) Receives $31.15 Average Price Target from Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned a consensus recommendation of “Buy” from the thirteen research firms that are covering the stock, Marketbeat.com reports. Thirteen analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $31.15.

A number of equities research analysts have recently weighed in on the company. Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Robert W. Baird cut their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, Truist Financial lifted their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th.

Insider Activity

In other Phreesia news, COO Evan Roberts sold 1,785 shares of the firm’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total value of $48,159.30. Following the completion of the transaction, the chief operating officer now directly owns 768,208 shares in the company, valued at $20,726,251.84. This trade represents a 0.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Amy Beth Vanduyn sold 1,311 shares of Phreesia stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $34,885.71. Following the completion of the transaction, the senior vice president now directly owns 115,633 shares in the company, valued at approximately $3,076,994.13. This trade represents a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 183,887 shares of company stock worth $5,146,862. Corporate insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Johnson Financial Group Inc. raised its stake in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd purchased a new position in shares of Phreesia during the fourth quarter valued at $30,000. International Assets Investment Management LLC raised its position in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares during the period. BankPlus Trust Department acquired a new position in Phreesia during the fourth quarter valued at $34,000. Finally, Quarry LP lifted its stake in Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after acquiring an additional 1,923 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Price Performance

Shares of NYSE PHR opened at $23.27 on Friday. Phreesia has a 1-year low of $17.07 and a 1-year high of $30.53. The firm has a market capitalization of $1.35 billion, a PE ratio of -15.83 and a beta of 1.03. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The business’s fifty day moving average price is $27.34 and its two-hundred day moving average price is $23.99.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same period last year, the firm posted ($0.58) EPS. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. On average, research analysts expect that Phreesia will post -1.1 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.